Company / SG&A per Share
Viking Therapeutics, Inc. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.43
FY2025
5-year range
$0.14 / $0.49
FY2021-FY2025
Trend
-11.9%
vs FY2024
Sector context
#175 of 210
Health Care
What the data says
Viking Therapeutics, Inc.'s sg&a per share of $0.43 is lower than 83% of companies in the Health Care sector (FY2025). SG&A per Share has fluctuated over the past 10 years, ranging from $0.10 in FY2019 to $0.52 in FY2016.
Based on SEC 10-K filings.
0.43 in FY2025 with a 5-year CAGR of +28.0%.
Increased from $0.14 to $0.43 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +46.9%
- 5-Year CAGR
- +28.0%
- 10-Year CAGR
- -
Sector benchmark
Top 17% in Health CareTop 17% of 210This company $0.43 Sector average $40.75
▼
-98.9% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share decreased 11.9% year-over-year.
- Ranks #175 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2016.
- Lowest sg&a per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.43 | -11.9% |
| FY2024 | $0.49 | +260.0% |
| FY2023 | $0.14 | -0.0% |
| FY2022 | $0.14 | -6.7% |
| FY2021 | $0.15 | +16.3% |
| FY2020 | $0.13 | +27.0% |
| FY2019 | $0.10 | -33.3% |
| FY2018 | $0.15 | -41.9% |
| FY2017 | $0.26 | -50.7% |
| FY2016 | $0.52 | +150.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026